Jianhua Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jianhua Zhou has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Lili Wang
Central Laboratories and Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China
3 shared publications Quanjiang Dong
Central Laboratories and Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao University, Qingdao, 266071, China
3 shared publicationsZhenggang Chen
Department of Stomatology, Qingdao Municipal Hospital, Qingdao University, Qingdao, 266071, China
3 shared publicationsJianzhong Qiu
Department of Stomatology, Qingdao Municipal Hospital, Qingdao, Shandong 266071, China
2 shared publicationsLili Wang
Central Laboratories , Qingdao Municipal Hospital , Qingdao , P.R. China
2 shared publicationsRongtao Yuan
Department of Stomatology, Qingdao Municipal Hospital, Qingdao University, Qingdao, 266071, China
2 shared publications
Latest Publications
- Open Access
- 26 July 2023
- Published by Walter de Gruyter GmbH in Journal of Laboratory Medicine
- Vol. 47 (5) , 187-197
Diagnostic accuracy of stool sample-based PCR in detecting Helicobacter pylori infection: a meta-analysis
The present study was to evaluate the diagnostic accuracy of different types of PCR tests with the aim of determining which one performs best for detecting Helicobacter pylori in stool samples. Related articles were searched from PubMed, Embase, Web of Science databases, Scopus, and Scholar Google. The quality of included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool and RevMan5.4 software. Pooled sensitivity, specificity, DOR, PLR and NLR for the stool PCR test in detecting H. pylori infection were performed by Stata 15.0 software. Subgroup meta-analysis was performed by Open Meta-analyst software. Ten studies were selected in this study. Stool PCR test had 92.0 % (83.0, 96.0 %) pooled sensitivity, 96.0 % (84.0, 99.0 %) pooled specificity, 296.0 (51.6, 1,696.9) pooled DOR, 26.1 (5.3, 128.7) pooled PLR and 0.09 (0.04, 0.18) NLR in the diagnosis of H. pylori infection, and summary receiver operating characteristic curve (SROC) illustrated an area under the curve (AUC) of 0.98. Subgroup meta-analysis showed rtPCR as having the highest diagnostic accuracy. Our results identify rtPCR as having the highest diagnostic accuracy for the detection of H. pylori in stool samples, and the stool PCR test as a reliable diagnostic tool for H. pylori infection.
- 26 July 2023
- Published by Walter de Gruyter GmbH in Journal of Laboratory Medicine
- Vol. 47 (5) , 187-197
Open AccessDiagnostic accuracy of stool sample-based PCR in detecting Helicobacter pylori infection: a meta-analysis
The present study was to evaluate the diagnostic accuracy of different types of PCR tests with the aim of determining which one performs best for detecting Helicobacter pylori in stool samples. Related articles were searched from PubMed, Embase, Web of Science databases, Scopus, and Scholar Google. The quality of included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool and RevMan5.4 software. Pooled sensitivity, specificity, DOR, PLR and NLR for the stool PCR test in detecting H. pylori infection were performed by Stata 15.0 software. Subgroup meta-analysis was performed by Open Meta-analyst software. Ten studies were selected in this study. Stool PCR test had 92.0 % (83.0, 96.0 %) pooled sensitivity, 96.0 % (84.0, 99.0 %) pooled specificity, 296.0 (51.6, 1,696.9) pooled DOR, 26.1 (5.3, 128.7) pooled PLR and 0.09 (0.04, 0.18) NLR in the diagnosis of H. pylori infection, and summary receiver operating characteristic curve (SROC) illustrated an area under the curve (AUC) of 0.98. Subgroup meta-analysis showed rtPCR as having the highest diagnostic accuracy. Our results identify rtPCR as having the highest diagnostic accuracy for the detection of H. pylori in stool samples, and the stool PCR test as a reliable diagnostic tool for H. pylori infection.
- Open Access
Microbial dysbiosis in oral squamous cell carcinoma: A systematic review and meta-analysis
- Open Access
- 1 July 2020
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 12, 5353-5363
Signatures of Mucosal Microbiome in Oral Squamous Cell Carcinoma Identified Using a Random Forest Model
Objective: The aim of this study was to explore the signatures of oral microbiome associated with OSCC using a random forest (RF) model. Patients and Methods: A total of 24 patients with OSCC were enrolled in the study. The oral microbiome was assessed in cancerous lesions and matched paracancerous tissues from each patient using 16S rRNA gene sequencing. Signatures of mucosal microbiome in OSCC were identified using a RF model. Results: Significant differences were found between OSCC lesions and matched paracancerous tissues with respect to the microbial profile and composition. Linear discriminant analysis effect size analyses (LEfSe) identified 15 bacteria genera associated with cancerous lesions. Fusobacterium, Treponema, Streptococcus, Peptostreptococcus, Carnobacterium, Tannerella, Parvimonas and Filifactor were enriched. A classifier based on RF model identified a microbial signature comprising 12 bacteria, which was capable of distinguishing cancerous lesions and paracancerous tissues (AUC = 0.82). The network of the oral microbiome in cancerous lesions appeared to be simplified and fragmented. Functional analyses of oral microbiome showed altered functions in amino acid metabolism and increased capacity of glucose utilization in OSCC. Conclusion: The identified microbial signatures may potentially be used as a biomarker for predicting OSCC or for clinical assessment of oral cancer risk.
- 1 July 2020
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 12, 5353-5363
Open AccessSignatures of Mucosal Microbiome in Oral Squamous Cell Carcinoma Identified Using a Random Forest Model
Objective: The aim of this study was to explore the signatures of oral microbiome associated with OSCC using a random forest (RF) model. Patients and Methods: A total of 24 patients with OSCC were enrolled in the study. The oral microbiome was assessed in cancerous lesions and matched paracancerous tissues from each patient using 16S rRNA gene sequencing. Signatures of mucosal microbiome in OSCC were identified using a RF model. Results: Significant differences were found between OSCC lesions and matched paracancerous tissues with respect to the microbial profile and composition. Linear discriminant analysis effect size analyses (LEfSe) identified 15 bacteria genera associated with cancerous lesions. Fusobacterium, Treponema, Streptococcus, Peptostreptococcus, Carnobacterium, Tannerella, Parvimonas and Filifactor were enriched. A classifier based on RF model identified a microbial signature comprising 12 bacteria, which was capable of distinguishing cancerous lesions and paracancerous tissues (AUC = 0.82). The network of the oral microbiome in cancerous lesions appeared to be simplified and fragmented. Functional analyses of oral microbiome showed altered functions in amino acid metabolism and increased capacity of glucose utilization in OSCC. Conclusion: The identified microbial signatures may potentially be used as a biomarker for predicting OSCC or for clinical assessment of oral cancer risk.
- Open Access
- 27 June 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-9
Simvastatin Improves the Jaw Bone Microstructural Defect Induced by High Cholesterol Diet in Rats by Regulating Autophagic Flux
Objective. The objective of this study is to evaluate the effect of simvastatin on the jaw bone microstructural defect and autophagy in rats with high cholesterol diet (HCD). Methods. Male Sprague-Dawley rats were fed a standard rodent chow (NC group) or a high cholesterol diet for 32 weeks and the HCD-fed rats were treated with vehicle (HC group) or simvastatin (5 mg/kg orally daily for 8 weeks, HC + SIM group, and /group). The static histomorphometric changes in the jaw bone tissues in individual rats were evaluated. The relative levels of OPG, RANKL, NF-κB, LC3, and p62 in the jaw bone tissues were determined by quantitative RT-PCR and/or immunohistochemistry. Results. Compared with the NC group, the HC groups had lower trabecular bone volume, trabecular thickness and trabecular number, and increased ratios of RANKL/OPG in the jaw bone, accompanied by enhanced NF-κB activation and autophagy. Simvastatin treatment inhabited these changes, including the decreased levels of serum proinflammatory cytokines and increased autophagy. Conclusion. Simvastatin treatment could inhibit the hyperlipidemia-induced jaw bone microstructural defect in rats by increasing autophagic flux.- 27 June 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-9
Open AccessSimvastatin Improves the Jaw Bone Microstructural Defect Induced by High Cholesterol Diet in Rats by Regulating Autophagic Flux
Objective. The objective of this study is to evaluate the effect of simvastatin on the jaw bone microstructural defect and autophagy in rats with high cholesterol diet (HCD). Methods. Male Sprague-Dawley rats were fed a standard rodent chow (NC group) or a high cholesterol diet for 32 weeks and the HCD-fed rats were treated with vehicle (HC group) or simvastatin (5 mg/kg orally daily for 8 weeks, HC + SIM group, and /group). The static histomorphometric changes in the jaw bone tissues in individual rats were evaluated. The relative levels of OPG, RANKL, NF-κB, LC3, and p62 in the jaw bone tissues were determined by quantitative RT-PCR and/or immunohistochemistry. Results. Compared with the NC group, the HC groups had lower trabecular bone volume, trabecular thickness and trabecular number, and increased ratios of RANKL/OPG in the jaw bone, accompanied by enhanced NF-κB activation and autophagy. Simvastatin treatment inhabited these changes, including the decreased levels of serum proinflammatory cytokines and increased autophagy. Conclusion. Simvastatin treatment could inhibit the hyperlipidemia-induced jaw bone microstructural defect in rats by increasing autophagic flux. - Open Access
- 29 September 2014
- Published by Spandidos Publications in Oncology Letters
- Vol. 8 (6) , 2675-2677
Giant keratocystic odontogenic tumor of the maxillary sinus and zygoma: A case report
Keratocystic odontogenic tumors (KCOTs), formally known as odontogenic keratocysts, are benign developmental tumors that are found primarily in the mandibular molar region and ascending ramus. The disease is characterized by aggressive growth and a high recurrence rate following surgical treatment. The present study reports the rare case of a 25‑year‑old male with a giant KCOT involving the right zygoma, maxillary bone and maxillary sinus. The tumor was removed using a modified treatment of enucleation, grinding and cryotherapy. Recurrence has not been observed within the eight‑month follow‑up period. The present study discusses the clinical features and surgical management of this case.
- 29 September 2014
- Published by Spandidos Publications in Oncology Letters
- Vol. 8 (6) , 2675-2677
Open AccessGiant keratocystic odontogenic tumor of the maxillary sinus and zygoma: A case report
Keratocystic odontogenic tumors (KCOTs), formally known as odontogenic keratocysts, are benign developmental tumors that are found primarily in the mandibular molar region and ascending ramus. The disease is characterized by aggressive growth and a high recurrence rate following surgical treatment. The present study reports the rare case of a 25‑year‑old male with a giant KCOT involving the right zygoma, maxillary bone and maxillary sinus. The tumor was removed using a modified treatment of enucleation, grinding and cryotherapy. Recurrence has not been observed within the eight‑month follow‑up period. The present study discusses the clinical features and surgical management of this case.